Compare 22nd Century Group Inc (XXII) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
22nd Century Group Inc vs Zimmer Biomet Holdings Inc — how do they compare? 22nd Century Group Inc trades at $4.25 (market cap $1.49M), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 11651× 22nd Century Group Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| XXII | ZBH | |
|---|---|---|
Market Cap | $1.49M | $17.36B |
Sector | Technology | Health |
52-Week High | $1.07K | $107.71 |
52-Week Low | $3.90 | $79.58 |
Enterprise Value | -$6.74M | $24.40B |
Dividend Yield | — | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
